Cargando…

Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia

BACKGROUND: Injecting-related bacterial and fungal infections are associated with significant morbidity and mortality among people who inject drugs (PWID), and they are increasing in incidence. Following hospitalization with an injecting-related infection, use of opioid agonist treatment (OAT; metha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brothers, Thomas D., Lewer, Dan, Jones, Nicola, Colledge-Frisby, Samantha, Farrell, Michael, Hickman, Matthew, Webster, Duncan, Hayward, Andrew, Degenhardt, Louisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295981/ https://www.ncbi.nlm.nih.gov/pubmed/35853024 http://dx.doi.org/10.1371/journal.pmed.1004049

Ejemplares similares

Modeling the population‐level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia
por: Chaillon, Antoine, et al.
Publicado: (2021)

Social and structural determinants of injecting-related bacterial and fungal infections among people who inject drugs: protocol for a mixed studies systematic review
por: Brothers, Thomas D, et al.
Publicado: (2021)

Mood and Anxiety Symptoms in Persons Taking Prescription Opioids: A Systematic Review with Meta-Analyses of Longitudinal Studies
por: Leung, Janni, et al.
Publicado: (2022)

The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study
por: Gisev, Natasa, et al.
Publicado: (2019)

The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: findings from the OATS retrospective linkage study.
por: Jones, Nicola, et al.
Publicado: (2022)

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
por: Bharat, Chrianna, et al.
Publicado: (2022)

Unequal access to opioid agonist treatment and sterile injecting equipment among hospitalized patients with injection drug use-associated infective endocarditis
por: Brothers, Thomas D., et al.
Publicado: (2022)

Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
por: Larney, Sarah, et al.
Publicado: (2018)

The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia
por: Day, Carolyn, et al.
Publicado: (2005)

Was an increase in cocaine use among injecting drug users in New South Wales, Australia, accompanied by an increase in violent crime?
por: Degenhardt, Louisa, et al.
Publicado: (2005)

Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia
por: Larance, Briony, et al.
Publicado: (2020)

Causes of death among people who used illicit opioids in England, 2001–18: a matched cohort study
por: Lewer, Dan, et al.
Publicado: (2021)

Cohort profile: POPPY II – a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia
por: Gisev, Natasa, et al.
Publicado: (2023)

Prescription opioid dispensing in New South Wales, Australia: spatial and temporal variation
por: Islam, M Mofizul, et al.
Publicado: (2018)

Estimating the number of people who inject drugs in Australia
por: Larney, Sarah, et al.
Publicado: (2017)

Fatal opioid overdoses during and shortly after hospital admissions in England: A case-crossover study
por: Lewer, Dan, et al.
Publicado: (2021)

The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia
por: Degenhardt, Louisa, et al.
Publicado: (2015)

Diarrhetic Shellfish Toxin Monitoring in Commercial Wild Harvest Bivalve Shellfish in New South Wales, Australia
por: Farrell, Hazel, et al.
Publicado: (2018)

Opioid Injection-Associated Bacterial Infections in England, 2002–2021: A Time Series Analysis of Seasonal Variation and the Impact of Coronavirus Disease 2019
por: Lewer, Dan, et al.
Publicado: (2023)

Opioid-related deaths during hospital admissions or shortly after discharge in the United Kingdom: A thematic framework analysis of coroner reports
por: Lewer, Dan, et al.
Publicado: (2023)

Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta‐analysis
por: Ferraro, Claire F., et al.
Publicado: (2021)

Depot buprenorphine as an opioid agonist therapy in New South Wales correctional centres: a costing model
por: Ling, R., et al.
Publicado: (2022)

Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross‐sectional survey of Australian treatment clients
por: Zahra, Emma, et al.
Publicado: (2022)

“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic
por: Conway, Anna, et al.
Publicado: (2023)

Injection Drug Use Frequency Before and After Take-Home Naloxone Training
por: Colledge-Frisby, Samantha, et al.
Publicado: (2023)

Rehospitalization for heart failure in the elderly
por: Ogbemudia, Ehimwenma J., et al.
Publicado: (2016)

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
por: Degenhardt, Louisa, et al.
Publicado: (2017)

Combating escalating harms associated with pharmaceutical opioid use in Australia: the POPPY II study protocol
por: Gisev, Natasa, et al.
Publicado: (2018)

Adverse drug reactions due to opioid analgesic use in New South Wales, Australia: a spatial-temporal analysis
por: Du, Wei, et al.
Publicado: (2019)

High COVID-19 death rates in prisons in England and Wales, and the need for early vaccination
por: Braithwaite, Isobel, et al.
Publicado: (2021)

Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol
por: Peacock, Amy, et al.
Publicado: (2018)

Caring for people who inject drugs when they are admitted to hospital
por: Brothers, Thomas D., et al.
Publicado: (2021)

Disparities in cataract surgery between Aboriginal and non-Aboriginal people in New South Wales, Australia
por: Randall, Deborah A, et al.
Publicado: (2014)

Drug use and risk behaviours among injecting drug users: a comparison between sex workers and non-sex workers in Sydney, Australia
por: Roxburgh, Amanda, et al.
Publicado: (2005)

Retirement intentions of dentists in New South Wales, Australia
por: Schofield, Deborah, et al.
Publicado: (2010)

Serological Immunity to Smallpox in New South Wales, Australia
por: Costantino, Valentina, et al.
Publicado: (2020)

Hospital Admission Due to Hypotension in Australia and in England and Wales
por: Hemmo, Sara Ibrahim, et al.
Publicado: (2023)

Les soins hospitaliers aux personnes qui consomment des drogues injectables
por: Brothers, Thomas D., et al.
Publicado: (2021)

Ixodes holocyclus Tick-Transmitted Human Pathogens in North-Eastern New South Wales, Australia
por: Graves, Stephen R., et al.
Publicado: (2016)

Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study
por: Larney, Sarah, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g0as8c9lujj8bev8ophv1i4snp